| Year |
Citation |
Score |
| 2024 |
Celià-Terrassa T, Kang Y. How important is EMT for cancer metastasis? Plos Biology. 22: e3002487. PMID 38324529 DOI: 10.1371/journal.pbio.3002487 |
0.329 |
|
| 2023 |
Nolan E, Kang Y, Malanchi I. Mechanisms of Organ-Specific Metastasis of Breast Cancer. Cold Spring Harbor Perspectives in Medicine. PMID 36987584 DOI: 10.1101/cshperspect.a041326 |
0.394 |
|
| 2022 |
Shen M, Kang Y. Cancer fitness genes: emerging therapeutic targets for metastasis. Trends in Cancer. PMID 36184492 DOI: 10.1016/j.trecan.2022.08.007 |
0.312 |
|
| 2022 |
Kumar S, Nandi A, Singh S, Regulapati R, Li N, Tobias JW, Siebel CW, Blanco MA, Klein-Szanto AJ, Lengner C, Welm AL, Kang Y, Chakrabarti R. Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway. Nature Communications. 13: 3927. PMID 35798701 DOI: 10.1038/s41467-022-30946-9 |
0.32 |
|
| 2022 |
Pérez-Núñez I, Rozalén C, Palomeque JÁ, Sangrador I, Dalmau M, Comerma L, Hernández-Prat A, Casadevall D, Menendez S, Liu DD, Shen M, Berenguer J, Ruiz IR, Peña R, Montañés JC, ... ... Kang Y, et al. LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer. Nature Cancer. PMID 35301507 DOI: 10.1038/s43018-022-00339-4 |
0.679 |
|
| 2022 |
Meng J, Jiang YZ, Zhao S, Tao Y, Zhang T, Wang X, Zhang Y, Sun K, Yuan M, Chen J, Wei Y, Lan X, Chen M, David CJ, Chang Z, ... ... Kang Y, et al. Tumor-derived Jagged1 promotes cancer progression through immune evasion. Cell Reports. 38: 110492. PMID 35263601 DOI: 10.1016/j.celrep.2022.110492 |
0.335 |
|
| 2021 |
Shen M, Smith HA, Wei Y, Jiang YZ, Zhao S, Wang N, Rowicki M, Tang Y, Hang X, Wu S, Wan L, Shao ZM, Kang Y. Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer. Nature Cancer. 3: 60-74. PMID 35121988 DOI: 10.1038/s43018-021-00280-y |
0.334 |
|
| 2021 |
Shen M, Wei Y, Kim H, Wan L, Jiang YZ, Hang X, Raba M, Remiszewski S, Rowicki M, Wu CG, Wu S, Zhang L, Lu X, Yuan M, Smith HA, ... ... Kang Y, et al. Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis. Nature Cancer. 3: 43-59. PMID 35121987 DOI: 10.1038/s43018-021-00279-5 |
0.34 |
|
| 2021 |
Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, García de Herreros A, ... ... Kang Y, et al. Author Correction: Guidelines and definitions for research on epithelial-mesenchymal transition. Nature Reviews. Molecular Cell Biology. PMID 34654908 DOI: 10.1038/s41580-021-00428-9 |
0.399 |
|
| 2021 |
Kumar S, Nandi A, Singh S, Regulapati R, Li N, Tobias JW, Siebel CW, Blanco MA, Klein-Szanto AJ, Lengner C, Welm AL, Kang Y, Chakrabarti R. Dll1 quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway. Nature Communications. 12: 432. PMID 33462238 DOI: 10.1038/s41467-020-20664-5 |
0.381 |
|
| 2020 |
Spadazzi C, Mercatali L, Esposito M, Wei Y, Liverani C, De Vita A, Miserocchi G, Carretta E, Zanoni M, Cocchi C, Bongiovanni A, Recine F, Kang Y, Ibrahim T. Trefoil Factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis. Bone. 115775. PMID 33249323 DOI: 10.1016/j.bone.2020.115775 |
0.377 |
|
| 2020 |
Fang C, Kang Y. Cellular Plasticity in Bone Metastasis. Bone. 115693. PMID 33069922 DOI: 10.1016/j.bone.2020.115693 |
0.376 |
|
| 2020 |
Song K, Cai X, Dong Y, Wu H, Wei Y, Shankavaram U, Cui K, Lee Y, Zhu B, Bhattacharjee S, Wang B, Zhang K, Wen A, Wong S, Yu L, ... ... Kang Y, et al. Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development. The Journal of Clinical Investigation. PMID 32960814 DOI: 10.1172/JCI129374 |
0.316 |
|
| 2020 |
Fan H, Wang X, Li W, Shen M, Wei Y, Zheng H, Kang Y. ASB13 inhibits breast cancer metastasis through promoting SNAI2 degradation and relieving its transcriptional repression of YAP. Genes & Development. PMID 32943576 DOI: 10.1101/Gad.339796.120 |
0.5 |
|
| 2020 |
Li W, Shen M, Jiang YZ, Zhang R, Zheng H, Wei Y, Shao ZM, Kang Y. Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2. Genes & Development. PMID 32943575 DOI: 10.1101/Gad.339804.120 |
0.453 |
|
| 2020 |
Pham K, Huynh D, Le L, Delitto D, Yang L, Huang J, Kang Y, Steinberg MB, Li J, Zhang L, Liu D, Tang MS, Liu C, Wang H. E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCAM-1. Cancer Letters. PMID 32829009 DOI: 10.1016/J.Canlet.2020.08.010 |
0.388 |
|
| 2020 |
Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S, Mark MT, Steiner L, Benito-Martin A, Lucotti S, Di Giannatale A, ... ... Kang Y, et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. PMID 32795414 DOI: 10.1016/J.Cell.2020.07.009 |
0.347 |
|
| 2020 |
Ghergurovich JM, Esposito M, Chen Z, Wang JZ, Bhatt V, Lan T, White E, Kang Y, Guo JY, Rabinowitz JD. Glucose-6-phosphate dehydrogenase is not essential for K-Ras-driven tumor growth or metastasis. Cancer Research. PMID 32661137 DOI: 10.1158/0008-5472.Can-19-2486 |
0.425 |
|
| 2020 |
Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, García de Herreros A, ... ... Kang Y, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nature Reviews. Molecular Cell Biology. PMID 32300252 DOI: 10.1038/S41580-020-0237-9 |
0.524 |
|
| 2020 |
Kang Y. Abstract IA13: Identification, validation, and therapeutic targeting of a driver gene in poor-prognosis breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-Ia13 |
0.451 |
|
| 2019 |
Shen M, Kang Y. Role Reversal: A Pro-metastatic Function of E-Cadherin. Developmental Cell. 51: 417-419. PMID 31743661 DOI: 10.1016/J.Devcel.2019.10.028 |
0.388 |
|
| 2019 |
Liverani C, De Vita A, Minardi S, Kang Y, Mercatali L, Amadori D, Bongiovanni A, La Manna F, Ibrahim T, Tasciotti E. A biomimetic 3D model of hypoxia-driven cancer progression. Scientific Reports. 9: 12263. PMID 31439905 DOI: 10.1038/S41598-019-48701-4 |
0.46 |
|
| 2019 |
Zijlstra A, Von Lersner A, Yu D, Borrello L, Oudin M, Kang Y, Sahai E, Fingleton B, Stein U, Cox TR, Price JT, Kato Y, Welm AL, Aguirre-Ghiso JA. The importance of developing therapies targeting the biological spectrum of metastatic disease. Clinical & Experimental Metastasis. PMID 31102066 DOI: 10.1007/S10585-019-09972-3 |
0.42 |
|
| 2019 |
Lu W, Kang Y. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis. Developmental Cell. 49: 361-374. PMID 31063755 DOI: 10.1016/J.Devcel.2019.04.010 |
0.442 |
|
| 2019 |
Esposito M, Mondal N, Greco TM, Wei Y, Spadazzi C, Lin SC, Zheng H, Cheung C, Magnani JL, Lin SH, Cristea IM, Sackstein R, Kang Y. Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis. Nature Cell Biology. PMID 30988423 DOI: 10.1038/S41556-019-0309-2 |
0.452 |
|
| 2019 |
Aiello NM, Kang Y. Context-dependent EMT programs in cancer metastasis. The Journal of Experimental Medicine. PMID 30975895 DOI: 10.1084/Jem.20181827 |
0.452 |
|
| 2019 |
Celià-Terrassa T, Bastian C, Liu DD, Ell B, Aiello NM, Wei Y, Zamalloa J, Blanco AM, Hang X, Kunisky D, Li W, Williams ED, Rabitz H, Kang Y. Author Correction: Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability. Nature Communications. 10: 527. PMID 30692542 DOI: 10.1038/S41467-019-08509-2 |
0.6 |
|
| 2019 |
Zhang H, Brown RL, Wei Y, Zhao P, Liu S, Liu X, Deng Y, Hu X, Zhang J, Gao XD, Kang Y, Mercurio AM, Goel HL, Cheng C. CD44 splice isoform switching determines breast cancer stem cell state. Genes & Development. PMID 30692202 DOI: 10.1101/Gad.319889.118 |
0.365 |
|
| 2019 |
Monsivais D, Peng J, Kang Y, Matzuk MM. Activin-like kinase 5 (ALK5) inactivation in the mouse uterus results in metastatic endometrial carcinoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 30655341 DOI: 10.1073/Pnas.1806838116 |
0.395 |
|
| 2019 |
Ponnapakkam T, Anbalagan M, Saeg F, Emneser W, Kang Y, Gensure R, Rowan B. OR30-4 Parathyroid Hormone-related Peptide Antagonist and Inverse Agonist Reduce Breast Cancer Metastasis to Bone and Bone Loss Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Or30-4 |
0.387 |
|
| 2019 |
Fan H, Wang X, Li W, Shen M, Wei Y, Zheng H, Kang Y. Abstract 162: ASB13 inhibits breast cancer progression and metastasis through SNAI2 degradation and transcriptional regulation of YAP Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-162 |
0.439 |
|
| 2018 |
Shen M, Jiang YZ, Wei Y, Ell B, Sheng X, Esposito M, Kang J, Hang X, Zheng H, Rowicki M, Zhang L, Shih WJ, Celià-Terrassa T, Liu Y, Cristea I, ... ... Kang Y, et al. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling. Cancer Cell. PMID 30612941 DOI: 10.1016/J.Ccell.2018.11.016 |
0.418 |
|
| 2018 |
Celià-Terrassa T, Bastian C, Liu D, Ell B, Aiello NM, Wei Y, Zamalloa J, Blanco AM, Hang X, Kunisky D, Li W, Williams ED, Rabitz H, Kang Y. Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability. Nature Communications. 9: 5005. PMID 30479345 DOI: 10.1038/S41467-018-07538-7 |
0.677 |
|
| 2018 |
Zhuo W, Liu Y, Li S, Guo D, Sun Q, Jin J, Rao X, Li M, Sun M, Jiang M, Xu Y, Teng L, Jin Y, Si J, Liu W, ... Kang Y, et al. Long Non-coding RNA GMAN, Upregulated in Gastric Cancer Tissues, is Associated with Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS. Gastroenterology. PMID 30445010 DOI: 10.1053/J.Gastro.2018.10.054 |
0.319 |
|
| 2018 |
Shen M, Kang Y. Complex interplay between tumor microenvironment and cancer therapy. Frontiers of Medicine. PMID 30097962 DOI: 10.1007/S11684-018-0663-7 |
0.396 |
|
| 2018 |
Celià-Terrassa T, Kang Y. Metastatic niche functions and therapeutic opportunities. Nature Cell Biology. 20: 868-877. PMID 30050120 DOI: 10.1038/S41556-018-0145-9 |
0.4 |
|
| 2018 |
Shen M, Kang Y. pSTAT3 Reactive Astrocytes Promote Brain Metastasis. Trends in Molecular Medicine. PMID 30029985 DOI: 10.1016/J.Molmed.2018.07.002 |
0.372 |
|
| 2018 |
Chakrabarti R, Celià-Terrassa T, Kumar S, Hang X, Wei Y, Choudhury A, Hwang J, Peng J, Nixon B, Grady JJ, DeCoste C, Gao J, van Es JH, Li MO, Aifantis I, ... ... Kang Y, et al. Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche. Science (New York, N.Y.). PMID 29773667 DOI: 10.1126/Science.Aan4153 |
0.328 |
|
| 2018 |
Anbalagan M, Ponnapakkam T, Kang Y, Gensure RC, Rowan BG. Abstract 4184: Novel parathyroid hormone antagonist prevents breast cancer bone metastasis and cortical bone destruction Tumor Biology. DOI: 10.1158/1538-7445.Am2018-4184 |
0.404 |
|
| 2017 |
Jin L, Chun J, Pan C, Kumar A, Zhang G, Ha Y, Li D, Alesi GN, Kang Y, Zhou L, Yu WM, Magliocca KR, Khuri FR, Qu CK, Metallo C, et al. The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer. Molecular Cell. PMID 29249655 DOI: 10.1016/J.Molcel.2017.11.025 |
0.394 |
|
| 2017 |
Zheng H, Bae Y, Kasimir-Bauer S, Tang R, Chen J, Ren G, Yuan M, Esposito M, Li W, Wei Y, Shen M, Zhang L, Tupitsyn N, Pantel K, King C, ... ... Kang Y, et al. Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy. Cancer Cell. 32: 731-747.e6. PMID 29232552 DOI: 10.1016/J.Ccell.2017.11.002 |
0.434 |
|
| 2017 |
Sánchez-Cid L, Pons M, Lozano JJ, Rubio N, Guerra-Rebollo M, Soriano A, Paris-Coderch L, Segura MF, Fueyo R, Arguimbau J, Zodda E, Bermudo R, Alonso I, Caparrós X, Cascante M, ... ... Kang Y, et al. MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells. Oncotarget. 8: 83384-83406. PMID 29137351 DOI: 10.18632/Oncotarget.20698 |
0.384 |
|
| 2017 |
Esposito M, Guise T, Kang Y. The Biology of Bone Metastasis. Cold Spring Harbor Perspectives in Medicine. PMID 29101110 DOI: 10.1101/Cshperspect.A031252 |
0.43 |
|
| 2017 |
Liu DD, Kang Y. Ets2 anchors the prometastatic function of mutant p53 in osteosarcoma. Genes & Development. 31: 1823-1824. PMID 29051386 DOI: 10.1101/Gad.307439.117 |
0.666 |
|
| 2017 |
Alečković M, Wei Y, LeRoy G, Sidoli S, Liu DD, Garcia BA, Kang Y. Identification of Nidogen 1 as a lung metastasis protein through secretome analysis. Genes & Development. PMID 28827399 DOI: 10.1101/Gad.301937.117 |
0.703 |
|
| 2017 |
Yang M, Bao W, Zhang X, Kang Y, Haffty B, Zhang L. Short-term and long-term clinical outcomes of uncommon types of invasive breast cancers. Histopathology. PMID 28746732 DOI: 10.1111/His.13328 |
0.364 |
|
| 2017 |
Aiello NM, Brabletz T, Kang Y, Nieto MA, Weinberg RA, Stanger BZ. Upholding a role for EMT in pancreatic cancer metastasis. Nature. 547: E7-E8. PMID 28682339 DOI: 10.1038/Nature22963 |
0.393 |
|
| 2017 |
Ye X, Brabletz T, Kang Y, Longmore GD, Nieto MA, Stanger BZ, Yang J, Weinberg RA. Upholding a role for EMT in breast cancer metastasis. Nature. 547: E1-E3. PMID 28682326 DOI: 10.1038/Nature22816 |
0.438 |
|
| 2017 |
Peng J, Kang Y. The Bony Side of Endothelial Cells in Prostate Cancer. Developmental Cell. 41: 451-452. PMID 28586639 DOI: 10.1016/J.Devcel.2017.05.015 |
0.372 |
|
| 2017 |
Celià-Terrassa T, Liu DD, Choudhury A, Hang X, Wei Y, Zamalloa J, Alfaro-Aco R, Chakrabarti R, Jiang YZ, Koh BI, Smith HA, DeCoste C, Li JJ, Shao ZM, Kang Y. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis. Nature Cell Biology. PMID 28530657 DOI: 10.1038/Ncb3533 |
0.661 |
|
| 2017 |
Zheng H, Li W, Kang Y. Tumor-Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic Implications. Cold Spring Harbor Symposia On Quantitative Biology. PMID 28381439 DOI: 10.1101/Sqb.2016.81.030775 |
0.409 |
|
| 2017 |
Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, Bissell MJ, Cox TR, Giaccia AJ, Erler JT, Hiratsuka S, et al. Pre-metastatic niches: organ-specific homes for metastases. Nature Reviews. Cancer. PMID 28303905 DOI: 10.1038/Nrc.2017.6 |
0.376 |
|
| 2017 |
Jin L, Chun J, Pan C, Alesi GN, Li D, Magliocca KR, Kang Y, Chen ZG, Shin DM, Khuri FR, Fan J, Kang S. Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis. Oncogene. PMID 28218905 DOI: 10.1038/Onc.2017.6 |
0.462 |
|
| 2017 |
Celià-Terrassa T, Kang Y. Mouse genomic screen reveals novel host regulator of metastasis. Genome Biology. 18: 31. PMID 28209174 DOI: 10.1186/S13059-017-1170-X |
0.343 |
|
| 2017 |
Li Z, Kang Y. Lipid Metabolism Fuels Cancer's Spread. Cell Metabolism. 25: 228-230. PMID 28178563 DOI: 10.1016/J.Cmet.2017.01.016 |
0.359 |
|
| 2017 |
Zhuo W, Kang Y. Lnc-ing ROR1-HER3 and Hippo signalling in metastasis. Nature Cell Biology. 19: 81-83. PMID 28139652 DOI: 10.1038/Ncb3467 |
0.429 |
|
| 2016 |
Peinado H, Alecˇković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar CM, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, ... ... Kang Y, et al. Corrigendum: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine. 22: 1502. PMID 27923027 DOI: 10.1038/Nm1216-1502B |
0.331 |
|
| 2016 |
Lu W, Kang Y. Cell lineage determinants as regulators of breast cancer metastasis. Cancer Metastasis Reviews. PMID 27866304 DOI: 10.1007/S10555-016-9644-Y |
0.504 |
|
| 2016 |
Kang Y. Dissecting Tumor-Stromal Interactions in Breast Cancer Bone Metastasis. Endocrinology and Metabolism (Seoul, Korea). PMID 27184014 DOI: 10.3803/Enm.2016.31.2.206 |
0.465 |
|
| 2016 |
Celià-Terrassa T, Kang Y. Distinctive properties of metastasis-initiating cells. Genes & Development. 30: 892-908. PMID 27083997 DOI: 10.1101/Gad.277681.116 |
0.412 |
|
| 2016 |
Li W, Kang Y. Probing the Fifty Shades of EMT in Metastasis. Trends in Cancer. 2: 65-67. PMID 27042694 DOI: 10.1016/J.Trecan.2016.01.001 |
0.348 |
|
| 2016 |
Alesi GN, Jin L, Li D, Magliocca KR, Kang Y, Chen ZG, Shin DM, Khuri FR, Kang S. RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis. Oncogene. PMID 27041561 DOI: 10.1038/Onc.2016.79 |
0.473 |
|
| 2016 |
Li Z, Kang Y. Emerging therapeutic targets in metastatic progression: a focus on breast cancer. Pharmacology & Therapeutics. PMID 27000769 DOI: 10.1016/J.Pharmthera.2016.03.003 |
0.449 |
|
| 2016 |
Hu JY, Yi W, Zhang MY, Xu R, Zeng LS, Long XR, Zhou XM, Zheng XS, Kang Y, Wang HY. MicroRNA-711 is a prognostic factor for poor overall survival and has an oncogenic role in breast cancer. Oncology Letters. 11: 2155-2163. PMID 26998141 DOI: 10.3892/Ol.2016.4217 |
0.401 |
|
| 2016 |
Zhao P, Xu Y, Wei Y, Qiu Q, Chew TL, Kang Y, Cheng C. The CD44s splice isoform is a central mediator for invadopodia activity. Journal of Cell Science. PMID 26869223 DOI: 10.1242/Jcs.171959 |
0.341 |
|
| 2016 |
Kang Y. Imaging TGFβ Signaling in Mouse Models of Cancer Metastasis. Methods in Molecular Biology (Clifton, N.J.). 1344: 219-32. PMID 26520127 DOI: 10.1007/978-1-4939-2966-5_13 |
0.48 |
|
| 2016 |
Ducker GS, Esposito MB, Kang Y, Rabinowitz JD. Abstract A14: Role of mitochondrial folate metabolism in cancer cell growth and proliferation Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-A14 |
0.321 |
|
| 2016 |
Chakrabarti R, Sinha S, Kang Y. Abstract B21: DNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signaling Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Devbiolca15-B21 |
0.462 |
|
| 2016 |
Rowan BG, Ponnapakkam T, Anbalagan M, Kang Y, Gensure RC. Abstract LB-259: Bone targeted parathyroid hormone antagonist for prevention of breast cancer bone metastases Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-259 |
0.44 |
|
| 2015 |
Bednarz-Knoll N, Efstathiou A, Gotzhein F, Wikman H, Mueller V, Kang Y, Pantel K. Potential Involvement of Jagged1 in Metastatic Progression of Human Breast Carcinomas. Clinical Chemistry. PMID 26721293 DOI: 10.1373/Clinchem.2015.246686 |
0.432 |
|
| 2015 |
Alečković M, Kang Y. Welcoming Treat: Astrocyte-Derived Exosomes Induce PTEN Suppression to Foster Brain Metastasis. Cancer Cell. 28: 554-6. PMID 26555172 DOI: 10.1016/J.Ccell.2015.10.010 |
0.39 |
|
| 2015 |
Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, ... ... Kang Y, et al. Tumour exosome integrins determine organotropic metastasis. Nature. PMID 26524530 DOI: 10.1038/Nature15756 |
0.376 |
|
| 2015 |
Ren G, Esposito M, Kang Y. Bone metastasis and the metastatic niche. Journal of Molecular Medicine (Berlin, Germany). PMID 26275789 DOI: 10.1007/S00109-015-1329-4 |
0.427 |
|
| 2015 |
Esposito M, Kang Y. RAI2: Linking Retinoic Acid Signaling with Metastasis Suppression. Cancer Discovery. 5: 466-8. PMID 25941336 DOI: 10.1158/2159-8290.Cd-15-0352 |
0.47 |
|
| 2015 |
Ale?kovi? M, Kang Y. Bone marrow stroma-derived miRNAs as regulators, biomarkers and therapeutic targets of bone metastasis. Bonekey Reports. 4: 671. PMID 25908970 DOI: 10.1038/Bonekey.2015.38 |
0.345 |
|
| 2015 |
Zheng H, Kang Y. Cradle of evil: osteogenic niche for early bone metastasis. Cancer Cell. 27: 153-5. PMID 25670074 DOI: 10.1016/J.Ccell.2015.01.006 |
0.475 |
|
| 2015 |
Chakrabarti R, Kang Y. Transplantable mouse tumor models of breast cancer metastasis. Methods in Molecular Biology (Clifton, N.J.). 1267: 367-80. PMID 25636479 DOI: 10.1007/978-1-4939-2297-0_18 |
0.466 |
|
| 2015 |
Ale?kovi? M, Kang Y. Regulation of cancer metastasis by cell-free miRNAs. Biochimica Et Biophysica Acta. 1855: 24-42. PMID 25450578 DOI: 10.1016/J.Bbcan.2014.10.005 |
0.356 |
|
| 2015 |
Kang Y. Abstract OI-1: Origin of Metastatic Traits in Breast Cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Oi-1 |
0.48 |
|
| 2015 |
La Manna F, Liverani C, De Vita A, Mercatali L, Spadazzi C, Kang Y, Bongiovanni A, Riva N, Ricci M, Calpona S, Amadori D, Ibrahim T. Tumor-stroma cross-talk in the study of the osteoclastogenic potential of a metastatic breast cancer cell line: a coculture system Annals of Oncology. 26: vi22. DOI: 10.1093/Annonc/Mdv336.61 |
0.438 |
|
| 2015 |
Liverani C, Mercatali L, Spadazzi C, De Vita A, La Manna F, Kang Y, Bongiovanni A, Riva N, Ricci M, Calpona S, Zavoiu V, Amadori D, Ibrahim T. Everolimus activity on breast cancer and bone cell cocultures Annals of Oncology. 26: vi19. DOI: 10.1093/Annonc/Mdv336.52 |
0.447 |
|
| 2014 |
Cicchini M, Chakrabarti R, Kongara S, Price S, Nahar R, Lozy F, Zhong H, Vazquez A, Kang Y, Karantza V. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Autophagy. 10: 2036-52. PMID 25483966 DOI: 10.4161/Auto.34398 |
0.473 |
|
| 2014 |
Guo F, Wan L, Zheng A, Stanevich V, Wei Y, Satyshur KA, Shen M, Lee W, Kang Y, Xing Y. Structural insights into the tumor-promoting function of the MTDH-SND1 complex. Cell Reports. 8: 1704-13. PMID 25242325 DOI: 10.1016/J.Celrep.2014.08.033 |
0.357 |
|
| 2014 |
Chakrabarti R, Wei Y, Hwang J, Hang X, Andres Blanco M, Choudhury A, Tiede B, Romano RA, DeCoste C, Mercatali L, Ibrahim T, Amadori D, Kannan N, Eaves CJ, Sinha S, ... Kang Y, et al. ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling. Nature Cell Biology. 16: 1004-15, 1-13. PMID 25241036 DOI: 10.1038/Ncb3040 |
0.435 |
|
| 2014 |
Zheng H, Shen M, Zha YL, Li W, Wei Y, Blanco MA, Ren G, Zhou T, Storz P, Wang HY, Kang Y. PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis. Cancer Cell. 26: 358-73. PMID 25203322 DOI: 10.1016/J.Ccr.2014.07.022 |
0.447 |
|
| 2014 |
Ell B, Kang Y. MicroRNAs as regulators of bone homeostasis and bone metastasis. Bonekey Reports. 3: 549. PMID 25120906 DOI: 10.1038/Bonekey.2014.44 |
0.323 |
|
| 2014 |
Wan L, Hu G, Wei Y, Yuan M, Bronson RT, Yang Q, Siddiqui J, Pienta KJ, Kang Y. Genetic ablation of metadherin inhibits autochthonous prostate cancer progression and metastasis. Cancer Research. 74: 5336-47. PMID 25074613 DOI: 10.1158/0008-5472.Can-14-1349 |
0.364 |
|
| 2014 |
Wan L, Lu X, Yuan S, Wei Y, Guo F, Shen M, Yuan M, Chakrabarti R, Hua Y, Smith HA, Blanco MA, Chekmareva M, Wu H, Bronson RT, Haffty BG, ... ... Kang Y, et al. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors. Cancer Cell. 26: 92-105. PMID 24981741 DOI: 10.1016/J.Ccr.2014.04.027 |
0.475 |
|
| 2014 |
Ell B, Qiu Q, Wei Y, Mercatali L, Ibrahim T, Amadori D, Kang Y. The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin. The Journal of Biological Chemistry. 289: 21888-95. PMID 24966325 DOI: 10.1074/Jbc.M114.582866 |
0.414 |
|
| 2014 |
Li W, Kang Y. A new Lnc in metastasis: long noncoding RNA mediates the prometastatic functions of TGF-β. Cancer Cell. 25: 557-9. PMID 24823634 DOI: 10.1016/J.Ccr.2014.04.014 |
0.372 |
|
| 2014 |
Wang Y, Lei R, Zhuang X, Zhang N, Pan H, Li G, Hu J, Pan X, Tao Q, Fu D, Xiao J, Chin YE, Kang Y, Yang Q, Hu G. DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis. The Journal of Clinical Investigation. 124: 1646-59. PMID 24590291 DOI: 10.1172/Jci71812 |
0.484 |
|
| 2014 |
Fan J, Shan C, Kang HB, Elf S, Xie J, Tucker M, Gu TL, Aguiar M, Lonning S, Chen H, Mohammadi M, Britton LM, Garcia BA, AleÄković M, Kang Y, et al. Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex. Molecular Cell. 53: 534-48. PMID 24486017 DOI: 10.1016/J.Molcel.2013.12.026 |
0.364 |
|
| 2014 |
Esposito M, Kang Y. Targeting tumor-stromal interactions in bone metastasis. Pharmacology & Therapeutics. 141: 222-33. PMID 24140083 DOI: 10.1016/J.Pharmthera.2013.10.006 |
0.415 |
|
| 2014 |
Deng Y, Huang Z, Xu Y, Jin J, Zhuo W, Zhang C, Zhang X, Shen M, Yan X, Wang L, Wang X, Kang Y, Si J, Zhou T. MiR-215 modulates gastric cancer cell proliferation by targeting RB1. Cancer Letters. 342: 27-35. PMID 23981575 DOI: 10.1016/J.Canlet.2013.08.033 |
0.333 |
|
| 2014 |
Cicchini M, Chakrabarti R, Kongara S, Price S, Nahar R, Lozy F, Zhong H, Vazquez A, Kang Y, Karantza V. Abstract LB-138: Autophagy regulator BECN1 acts as a context-dependent tumor suppressor opposing parity-associated and WNT1-driven mammary tumorigenesis Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-138 |
0.47 |
|
| 2014 |
Esposito M, Magnani JL, Kang Y. Abstract 4039: Exploration of a potent E-Selectin antagonist (GMI-1271) as a potential novel therapeutic for treating breast cancer metastasis to the bone and lung Cancer Research. 74: 4039-4039. DOI: 10.1158/1538-7445.Am2014-4039 |
0.458 |
|
| 2014 |
Bednarz-Knoll N, Efstathiou A, Gotzhein F, Wilkman H, Mueller V, Kang Y, Pantel K. 328 Jagged1 expression and its relevance in metastatic progression of breast cancers European Journal of Cancer. 50: 106-107. DOI: 10.1016/S0959-8049(14)70454-X |
0.424 |
|
| 2013 |
Ell B, Kang Y. MicroRNAs as regulators of tumor-associated stromal cells. Oncotarget. 4: 2166-7. PMID 24293477 DOI: 10.18632/Oncotarget.1625 |
0.378 |
|
| 2013 |
Wan L, Pantel K, Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nature Medicine. 19: 1450-64. PMID 24202397 DOI: 10.1038/Nm.3391 |
0.43 |
|
| 2013 |
Ell B, Mercatali L, Ibrahim T, Campbell N, Schwarzenbach H, Pantel K, Amadori D, Kang Y. Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis. Cancer Cell. 24: 542-56. PMID 24135284 DOI: 10.1016/J.Ccr.2013.09.008 |
0.354 |
|
| 2013 |
Smith HA, Kang Y. Acute infection induces a metastatic niche: a double menace for cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4547-9. PMID 23922303 DOI: 10.1158/1078-0432.Ccr-13-1524 |
0.351 |
|
| 2013 |
Wan L, Kang Y. Pleiotropic roles of AEG-1/MTDH/LYRIC in breast cancer. Advances in Cancer Research. 120: 113-34. PMID 23889989 DOI: 10.1016/B978-0-12-401676-7.00004-8 |
0.483 |
|
| 2013 |
Ell B, Kang Y. Transcriptional control of cancer metastasis. Trends in Cell Biology. 23: 603-11. PMID 23838335 DOI: 10.1016/J.Tcb.2013.06.001 |
0.399 |
|
| 2013 |
Leroy G, Dimaggio PA, Chan EY, Zee BM, Blanco MA, Bryant B, Flaniken IZ, Liu S, Kang Y, Trojer P, Garcia BA. A quantitative atlas of histone modification signatures from human cancer cells. Epigenetics & Chromatin. 6: 20. PMID 23826629 DOI: 10.1186/1756-8935-6-20 |
0.365 |
|
| 2013 |
Lee ST, Feng M, Wei Y, Li Z, Qiao Y, Guan P, Jiang X, Wong CH, Huynh K, Wang J, Li J, Karuturi KM, Tan EY, Hoon DS, Kang Y, et al. Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis. Proceedings of the National Academy of Sciences of the United States of America. 110: 11121-6. PMID 23784775 DOI: 10.1073/Pnas.1300873110 |
0.419 |
|
| 2013 |
Goode GD, Ballard BR, Manning HC, Freeman ML, Kang Y, Eltom SE. Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line. International Journal of Cancer. Journal International Du Cancer. 133: 2769-80. PMID 23733406 DOI: 10.1002/Ijc.28297 |
0.468 |
|
| 2013 |
Kang Y, Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell. 23: 573-81. PMID 23680145 DOI: 10.1016/J.Ccr.2013.04.017 |
0.375 |
|
| 2013 |
Hitosugi T, Zhou L, Fan J, Elf S, Zhang L, Xie J, Wang Y, Gu TL, Alečković M, LeRoy G, Kang Y, Kang HB, Seo JH, Shan C, Jin P, et al. Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation. Nature Communications. 4: 1790. PMID 23653202 DOI: 10.1038/Ncomms2759 |
0.372 |
|
| 2013 |
Zheng H, Kang Y. Multilayer control of the EMT master regulators. Oncogene. 33: 1755-63. PMID 23604123 DOI: 10.1038/Onc.2013.128 |
0.481 |
|
| 2013 |
Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. Journal of Molecular Medicine (Berlin, Germany). 91: 411-29. PMID 23515621 DOI: 10.1007/S00109-013-1021-5 |
0.393 |
|
| 2013 |
Lee JY, Park MK, Park JH, Lee HJ, Shin DH, Kang Y, Lee CH, Kong G. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Oncogene. 33: 1325-35. PMID 23474752 DOI: 10.1038/Onc.2013.53 |
0.379 |
|
| 2013 |
Ren G, Kang Y. A one-two punch of miR-126/126* against metastasis. Nature Cell Biology. 15: 231-3. PMID 23449143 DOI: 10.1038/Ncb2703 |
0.32 |
|
| 2013 |
DeGraff DJ, Robinson VL, Shah JB, Brandt WD, Sonpavde G, Kang Y, Liebert M, Wu XR, Taylor JA. Current preclinical models for the advancement of translational bladder cancer research. Molecular Cancer Therapeutics. 12: 121-30. PMID 23269072 DOI: 10.1158/1535-7163.Mct-12-0508 |
0.38 |
|
| 2013 |
Mercatali L, Kang Y, Zanoni M, Liverani C, Carretta E, Ricci M, Riva N, Calpona S, Bongiovanni A, Zoli W, Amadori D, Ibrahim T. Trefoil factor 1 as a predictive factor of bone metastases in breast cancer. Journal of Clinical Oncology. 31: 11022-11022. DOI: 10.1200/Jco.2013.31.15_Suppl.11022 |
0.409 |
|
| 2013 |
Kang Y. Abstract IA02: Tumor plasticity and reactive stroma in breast cancer metastasis Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-Ia02 |
0.542 |
|
| 2013 |
Cicchini M, Chakarbarti R, Kongara S, Nahar R, Lozy F, Vasquez A, Kang Y, Karantza V. Abstract A004: Expansion of immature mammary epithelial populations promotesWnt1-driven mammary tumorigenesis in an autophagy-deficient mouse model Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-A004 |
0.439 |
|
| 2013 |
Kang Y. Abstract IA6: Epithelial-mesenchymal plasticity in breast cancer metastasis Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-Ia6 |
0.502 |
|
| 2013 |
Kang Y. Abstract IA27: Cell fate determinants as regulators of cancer metastasis Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Ia27 |
0.481 |
|
| 2013 |
Lyden D, Peinado-Selgas H, Nitadori A, Shen T, Aleckovic M, Kang Y, Bromberg J. Abstract BS03-1: Tumor-derived exosomes promote pre-metastatic niche formation and organotropism Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-Bs03-1 |
0.449 |
|
| 2012 |
Sethi N, Kang Y. Notch signaling: mediator and therapeutic target of bone metastasis. Bonekey Reports. 1: 3. PMID 23951415 DOI: 10.1038/Bonekey.2012.2 |
0.388 |
|
| 2012 |
Fang W, Wei Y, Kang Y, Landweber LF. Detection of a common chimeric transcript between human chromosomes 7 and 16. Biology Direct. 7: 49. PMID 23273016 DOI: 10.1186/1745-6150-7-49 |
0.312 |
|
| 2012 |
Hitosugi T, Zhou L, Elf S, Fan J, Kang HB, Seo JH, Shan C, Dai Q, Zhang L, Xie J, Gu TL, Jin P, Alečković M, LeRoy G, Kang Y, et al. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell. 22: 585-600. PMID 23153533 DOI: 10.1016/J.Ccr.2012.09.020 |
0.408 |
|
| 2012 |
Ell B, Kang Y. SnapShot: Bone Metastasis. Cell. 151: 690-690.e1. PMID 23101634 DOI: 10.1016/J.Cell.2012.10.005 |
0.323 |
|
| 2012 |
Chakrabarti R, Hwang J, Andres Blanco M, Wei Y, Lukačišin M, Romano RA, Smalley K, Liu S, Yang Q, Ibrahim T, Mercatali L, Amadori D, Haffty BG, Sinha S, Kang Y. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nature Cell Biology. 14: 1212-22. PMID 23086238 DOI: 10.1038/Ncb2607 |
0.493 |
|
| 2012 |
Liang Y, Wu H, Lei R, Chong RA, Wei Y, Lu X, Tagkopoulos I, Kung SY, Yang Q, Hu G, Kang Y. Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis. The Journal of Biological Chemistry. 287: 33533-44. PMID 22875853 DOI: 10.1074/Jbc.M112.392332 |
0.481 |
|
| 2012 |
Wendt MK, Schiemann BJ, Parvani JG, Lee YH, Kang Y, Schiemann WP. TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer. Oncogene. 32: 2005-15. PMID 22710711 DOI: 10.1038/Onc.2012.230 |
0.472 |
|
| 2012 |
Blanco MA, LeRoy G, Khan Z, Alečković M, Zee BM, Garcia BA, Kang Y. Global secretome analysis identifies novel mediators of bone metastasis. Cell Research. 22: 1339-55. PMID 22688892 DOI: 10.1038/Cr.2012.89 |
0.401 |
|
| 2012 |
Peinado H, Ale?kovi? M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, ... ... Kang Y, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine. 18: 883-91. PMID 22635005 DOI: 10.1038/Nm.2753 |
0.396 |
|
| 2012 |
Chakrabarti R, Wei Y, Romano RA, DeCoste C, Kang Y, Sinha S. Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. Stem Cells (Dayton, Ohio). 30: 1496-508. PMID 22523003 DOI: 10.1002/Stem.1112 |
0.354 |
|
| 2012 |
Celià -Terrassa T, Meca-Cortés O, Mateo F, de Paz AM, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, DÃaz A, Guerra-Rebollo M, Lozano JJ, Estarás C, Ulloa C, Ãlvarez-Simón D, Milà J, ... ... Kang Y, et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. The Journal of Clinical Investigation. 122: 1849-68. PMID 22505459 DOI: 10.1172/Jci59218 |
0.444 |
|
| 2012 |
Koh BI, Kang Y. The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells. Embo Reports. 13: 412-22. PMID 22473297 DOI: 10.1038/Embor.2012.41 |
0.418 |
|
| 2012 |
Kang Y. Abstract BS1-2: Reactive Stroma as Therapeutic Targets in Breast Cancer Bone Metastasis Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Bs1-2 |
0.49 |
|
| 2011 |
Lu X, Mu E, Wei Y, Riethdorf S, Yang Q, Yuan M, Yan J, Hua Y, Tiede BJ, Lu X, Haffty BG, Pantel K, Massagué J, Kang Y. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell. 20: 701-14. PMID 22137794 DOI: 10.1016/J.Ccr.2011.11.002 |
0.618 |
|
| 2011 |
Sethi N, Kang Y. Notch signalling in cancer progression and bone metastasis. British Journal of Cancer. 105: 1805-10. PMID 22075946 DOI: 10.1038/bjc.2011.497 |
0.311 |
|
| 2011 |
Sethi N, Kang Y. Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nature Reviews. Cancer. 11: 735-48. PMID 21941285 DOI: 10.1038/Nrc3125 |
0.344 |
|
| 2011 |
Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celià -Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, Wei Y, Hu G, Garcia BA, Ragoussis J, Amadori D, ... ... Kang Y, et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nature Medicine. 17: 1101-8. PMID 21822286 DOI: 10.1038/Nm.2401 |
0.376 |
|
| 2011 |
Ibrahim T, Sacanna E, Gaudio M, Mercatali L, Scarpi E, Zoli W, Serra P, Ricci R, Serra L, Kang Y, Amadori D. Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients. Clinical Breast Cancer. 11: 369-75. PMID 21764390 DOI: 10.1016/J.Clbc.2011.05.001 |
0.405 |
|
| 2011 |
Zhang X, Tamasi J, Lu X, Zhu J, Chen H, Tian X, Lee TC, Threadgill DW, Kream BE, Kang Y, Partridge NC, Qin L. Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 1022-34. PMID 21542005 DOI: 10.1002/Jbmr.295 |
0.316 |
|
| 2011 |
Lu X, Kang Y. Cell fusion hypothesis of the cancer stem cell. Advances in Experimental Medicine and Biology. 714: 129-40. PMID 21506011 DOI: 10.1007/978-94-007-0782-5_6 |
0.425 |
|
| 2011 |
Mercatali L, Ibrahim T, Sacanna E, Flamini E, Scarpi E, Calistri D, Ricci M, Serra P, Ricci R, Zoli W, Kang Y, Amadori D. Bone metastases detection by circulating biomarkers: OPG and RANK-L. International Journal of Oncology. 39: 255-61. PMID 21491082 DOI: 10.3892/Ijo.2011.1001 |
0.319 |
|
| 2011 |
Blanco MA, Alečković M, Hua Y, Li T, Wei Y, Xu Z, Cristea IM, Kang Y. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. The Journal of Biological Chemistry. 286: 19982-92. PMID 21478147 DOI: 10.1074/Jbc.M111.240077 |
0.467 |
|
| 2011 |
Blanco MA, Kang Y. Signaling pathways in breast cancer metastasis - novel insights from functional genomics. Breast Cancer Research : Bcr. 13: 206. PMID 21457525 DOI: 10.1186/Bcr2831 |
0.436 |
|
| 2011 |
Matsushima K, Isomoto H, Yamaguchi N, Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S, Nagayasu T, Nakashima M, Ujifuku K, Mitsutake N, Ohtsuru A, Yamashita S, ... ... Kang Y, et al. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. Journal of Translational Medicine. 9: 30. PMID 21426561 DOI: 10.1186/1479-5876-9-30 |
0.31 |
|
| 2011 |
Sethi N, Dai X, Winter CG, Kang Y. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell. 19: 192-205. PMID 21295524 DOI: 10.1016/J.Ccr.2010.12.022 |
0.451 |
|
| 2011 |
Tiede B, Kang Y. From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer. Cell Research. 21: 245-57. PMID 21243011 DOI: 10.1038/Cr.2011.11 |
0.441 |
|
| 2011 |
Sethi N, Kang Y. Dysregulation of developmental pathways in bone metastasis. Bone. 48: 16-22. PMID 20630490 DOI: 10.1016/J.Bone.2010.07.005 |
0.436 |
|
| 2010 |
Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5928-35. PMID 20962028 DOI: 10.1158/1078-0432.Ccr-10-1360 |
0.378 |
|
| 2010 |
Sethi N, Yan Y, Quek D, Schupbach T, Kang Y. Rabconnectin-3 is a functional regulator of mammalian Notch signaling. The Journal of Biological Chemistry. 285: 34757-64. PMID 20810660 DOI: 10.1074/Jbc.M110.158634 |
0.311 |
|
| 2010 |
Lu X, Lu X, Kang Y. Organ-specific enhancement of metastasis by spontaneous ploidy duplication and cell size enlargement. Cell Research. 20: 1012-22. PMID 20603645 DOI: 10.1038/Cr.2010.93 |
0.483 |
|
| 2010 |
Ganapathy V, Ge R, Grazioli A, Xie W, Banach-Petrosky W, Kang Y, Lonning S, McPherson J, Yingling JM, Biswas S, Mundy GR, Reiss M. Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis. Molecular Cancer. 9: 122. PMID 20504320 DOI: 10.1186/1476-4598-9-122 |
0.358 |
|
| 2010 |
Lu X, Yan CH, Yuan M, Wei Y, Hu G, Kang Y. In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer. Cancer Research. 70: 3905-14. PMID 20442288 DOI: 10.1158/0008-5472.Can-09-3739 |
0.46 |
|
| 2010 |
Korpal M, Kang Y. Targeting the transforming growth factor-beta signalling pathway in metastatic cancer. European Journal of Cancer (Oxford, England : 1990). 46: 1232-40. PMID 20307969 DOI: 10.1016/J.Ejca.2010.02.040 |
0.322 |
|
| 2010 |
Lu X, Bennet B, Mu E, Rabinowitz J, Kang Y. Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model Journal of Biological Chemistry. 285: 9317-9321. PMID 20139083 DOI: 10.1074/Jbc.C110.104448 |
0.438 |
|
| 2010 |
Lu X, Yang Q, Yuan M, Mu E, Reiss M, Haffty B, Massagué J, Kang Y. Abstract 5763: VCAM1 mediates aggressive bone metastasis outbreak from tumor dormancy by engaging α4β1-positive osteoclast progenitor cells Cancer Research. 70: 5763-5763. DOI: 10.1158/1538-7445.Am10-5763 |
0.632 |
|
| 2010 |
Blanco MA, LeRoy G, Zee B, Aleckovic M, Garcia B, Kang Y. Abstract B7: The bone metastasis secretome: Identification of potential therapeutic targets via high-throughput proteomics Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcme10-B7 |
0.414 |
|
| 2009 |
Steeg PS, Anderson RL, Bar-Eli M, Chambers AF, Eccles SA, Hunter K, Itoh K, Kang Y, Matrisian LM, Sleeman JP, Theodorescu D, Thompson EW, Welch DR. An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4529. PMID 25278743 DOI: 10.1158/1078-0432.Ccr-09-1363 |
0.319 |
|
| 2009 |
Lu X, Kang Y. Epidermal growth factor signalling and bone metastasis. British Journal of Cancer. 102: 457-61. PMID 20010942 DOI: 10.1038/sj.bjc.6605490 |
0.316 |
|
| 2009 |
Tiede BJ, Owens LA, Li F, DeCoste C, Kang Y. A novel mouse model for non-invasive single marker tracking of mammary stem cells in vivo reveals stem cell dynamics throughout pregnancy. Plos One. 4: e8035. PMID 19946375 DOI: 10.1371/Journal.Pone.0008035 |
0.338 |
|
| 2009 |
Lu X, Kang Y. Metalloproteinases and osteoblast EGFR signaling in osteolytic bone metastasis of breast cancer. Cell Cycle (Georgetown, Tex.). 8: 3804-5. PMID 19934661 DOI: 10.4161/Cc.8.23.10104 |
0.44 |
|
| 2009 |
Lu X, Kang Y. Cell fusion as a hidden force in tumor progression. Cancer Research. 69: 8536-9. PMID 19887616 DOI: 10.1158/0008-5472.Can-09-2159 |
0.433 |
|
| 2009 |
Hu G, Wei Y, Kang Y. The multifaceted role of MTDH/AEG-1 in cancer progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5615-20. PMID 19723648 DOI: 10.1158/1078-0432.Ccr-09-0049 |
0.461 |
|
| 2009 |
Lu X, Kang Y. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. The Journal of Biological Chemistry. 284: 29087-96. PMID 19720836 DOI: 10.1074/Jbc.M109.035899 |
0.492 |
|
| 2009 |
Hu G, Kang Y, Wang XF. From breast to the brain: unraveling the puzzle of metastasis organotropism. Journal of Molecular Cell Biology. 1: 3-5. PMID 19633017 DOI: 10.1093/Jmcb/Mjp005 |
0.468 |
|
| 2009 |
Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M, Massagué J, Kang Y. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes & Development. 23: 1882-94. PMID 19608765 DOI: 10.1101/Gad.1824809 |
0.597 |
|
| 2009 |
Korpal M, Yan J, Lu X, Xu S, Lerit DA, Kang Y. Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis. Nature Medicine. 15: 960-6. PMID 19597504 DOI: 10.1038/Nm.1943 |
0.337 |
|
| 2009 |
Kang Y. Analysis of cancer stem cell metastasis in xenograft animal models. Methods in Molecular Biology (Clifton, N.J.). 568: 7-19. PMID 19582418 DOI: 10.1007/978-1-59745-280-9_2 |
0.482 |
|
| 2009 |
Wei Y, Hu G, Kang Y. Metadherin as a link between metastasis and chemoresistance. Cell Cycle (Georgetown, Tex.). 8: 2132-3. PMID 19556872 DOI: 10.4161/Cc.8.14.9070 |
0.375 |
|
| 2009 |
Lu X, Kang Y. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proceedings of the National Academy of Sciences of the United States of America. 106: 9385-90. PMID 19458257 DOI: 10.1073/Pnas.0900108106 |
0.463 |
|
| 2009 |
Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, Li F, Reiss M, Au JL, Haffty BG, Kang Y. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell. 15: 9-20. PMID 19111877 DOI: 10.1016/J.Ccr.2008.11.013 |
0.431 |
|
| 2008 |
Korpal M, Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. Rna Biology. 5: 115-9. PMID 19182522 DOI: 10.4161/Rna.5.3.6558 |
0.322 |
|
| 2008 |
Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. The Journal of Biological Chemistry. 283: 14910-4. PMID 18411277 DOI: 10.1074/Jbc.C800074200 |
0.354 |
|
| 2007 |
Zhu J, Jia X, Xiao G, Kang Y, Partridge NC, Qin L. EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts: implications for osteolytic bone metastases. The Journal of Biological Chemistry. 282: 26656-64. PMID 17636266 DOI: 10.1074/Jbc.M705064200 |
0.41 |
|
| 2007 |
Lu X, Kang Y. Organotropism of breast cancer metastasis. Journal of Mammary Gland Biology and Neoplasia. 12: 153-62. PMID 17566854 DOI: 10.1007/S10911-007-9047-3 |
0.461 |
|
| 2007 |
Li F, Tiede B, Massagué J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Research. 17: 3-14. PMID 17179981 DOI: 10.1038/Sj.Cr.7310118 |
0.626 |
|
| 2006 |
Kang Y. New tricks against an old foe: molecular dissection of metastasis tissue tropism in breast cancer. Breast Disease. 26: 129-38. PMID 17473371 DOI: 10.3233/Bd-2007-26111 |
0.468 |
|
| 2006 |
Kang Y. Pro-metastasis function of TGFbeta mediated by the Smad pathway. Journal of Cellular Biochemistry. 98: 1380-90. PMID 16598746 DOI: 10.1002/jcb.20928 |
0.352 |
|
| 2006 |
Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL, Massagué J. Erratum: Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway (Proceedings of the National Academy of Sciences of the United States of America) (September 27, 2005) 102 (13909-13914) DOI: 10.1073/pnas.0506517102)) Proceedings of the National Academy of Sciences of the United States of America. 103. DOI: 10.1073/Pnas.0603221103 |
0.608 |
|
| 2005 |
Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I, Cordón-Cardo C, Olshen AB, Gerald WL, Massagué J. Identifying site-specific metastasis genes and functions. Cold Spring Harbor Symposia On Quantitative Biology. 70: 149-58. PMID 16869748 DOI: 10.1101/Sqb.2005.70.018 |
0.672 |
|
| 2005 |
Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL, Massagué J. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proceedings of the National Academy of Sciences of the United States of America. 102: 13909-14. PMID 16172383 DOI: 10.1073/Pnas.0506517102 |
0.751 |
|
| 2005 |
Kang Y. Functional genomic analysis of cancer metastasis: biologic insights and clinical implications. Expert Review of Molecular Diagnostics. 5: 385-95. PMID 15934815 DOI: 10.1586/14737159.5.3.385 |
0.388 |
|
| 2005 |
Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massagué J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. The Journal of Clinical Investigation. 115: 44-55. PMID 15630443 DOI: 10.1172/Jci22320 |
0.745 |
|
| 2004 |
Kang Y. Breast cancer bone metastasis: Molecular basis of tissue tropism Journal of Musculoskeletal Neuronal Interactions. 4: 379-380. PMID 15758269 |
0.321 |
|
| 2004 |
Kang Y, Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 118: 277-9. PMID 15294153 DOI: 10.1016/J.Cell.2004.07.011 |
0.605 |
|
| 2003 |
Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, Massagué J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 3: 537-49. PMID 12842083 DOI: 10.1016/S1535-6108(03)00132-6 |
0.485 |
|
| 2003 |
Kang Y, Chen CR, Massagué J. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Molecular Cell. 11: 915-26. PMID 12718878 DOI: 10.1016/S1097-2765(03)00109-6 |
0.508 |
|
| 2002 |
Xu L, Kang Y, Cöl S, Massagué J. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Molecular Cell. 10: 271-82. PMID 12191473 DOI: 10.1016/S1097-2765(02)00586-5 |
0.495 |
|
| 2002 |
Chen CR, Kang Y, Siegel PM, Massagué J. E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell. 110: 19-32. PMID 12150994 DOI: 10.1016/S0092-8674(02)00801-2 |
0.318 |
|
| 2002 |
Ho DN, Coburn GA, Kang Y, Cullen BR, Georgiadis MM. The crystal structure and mutational analysis of a novel RNA-binding domain found in the human Tap nuclear mRNA export factor. Proceedings of the National Academy of Sciences of the United States of America. 99: 1888-93. PMID 11854490 DOI: 10.1073/Pnas.042698599 |
0.472 |
|
| 2002 |
Wiegand HL, Coburn GA, Zeng Y, Kang Y, Bogerd HP, Cullen BR. Formation of Tap/NXT1 heterodimers activates Tap-dependent nuclear mRNA export by enhancing recruitment to nuclear pore complexes. Molecular and Cellular Biology. 22: 245-56. PMID 11739738 DOI: 10.1128/Mcb.22.1.245-256.2002 |
0.507 |
|
| 2001 |
Coburn GA, Wiegand HL, Kang Y, Ho DN, Georgiadis MM, Cullen BR. Using viral species specificity to define a critical protein/RNA interaction surface. Genes & Development. 15: 1194-205. PMID 11358864 DOI: 10.1101/Gad.888201 |
0.505 |
|
| 2001 |
Chen CR, Kang Y, Massagué J. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program Proceedings of the National Academy of Sciences of the United States of America. 98: 992-999. PMID 11158583 DOI: 10.1073/Pnas.98.3.992 |
0.566 |
|
| 2000 |
Neufeld KL, Nix DA, Bogerd H, Kang Y, Beckerle MC, Cullen BR, White RL. Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proceedings of the National Academy of Sciences of the United States of America. 97: 12085-90. PMID 11035805 DOI: 10.1073/Pnas.220401797 |
0.503 |
|
| 2000 |
Kang Y, Bogerd HP, Cullen BR. Analysis of cellular factors that mediate nuclear export of RNAs bearing the Mason-Pfizer monkey virus constitutive transport element. Journal of Virology. 74: 5863-71. PMID 10846066 DOI: 10.1128/Jvi.74.13.5863-5871.2000 |
0.499 |
|
| 1999 |
Truant R, Kang Y, Cullen BR. The human tap nuclear RNA export factor contains a novel transportin-dependent nuclear localization signal that lacks nuclear export signal function. The Journal of Biological Chemistry. 274: 32167-71. PMID 10542253 DOI: 10.1074/Jbc.274.45.32167 |
0.492 |
|
| 1999 |
Kang Y, Bogerd HP, Yang J, Cullen BR. Analysis of the RNA binding specificity of the human tap protein, a constitutive transport element-specific nuclear RNA export factor. Virology. 262: 200-9. PMID 10489353 DOI: 10.1006/Viro.1999.9906 |
0.485 |
|
| 1999 |
Kang Y, Cullen BR. The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences. Genes & Development. 13: 1126-39. PMID 10323864 DOI: 10.1101/Gad.13.9.1126 |
0.501 |
|
| 1998 |
Kang Y, Cullen BR. Derivation and functional characterization of a consensus DNA binding sequence for the tas transcriptional activator of simian foamy virus type 1. Journal of Virology. 72: 5502-9. PMID 9621006 DOI: 10.1128/Jvi.72.7.5502-5509.1998 |
0.475 |
|
| 1998 |
Kang Y, Blair WS, Cullen BR. Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter. Journal of Virology. 72: 504-11. PMID 9420252 DOI: 10.1128/Jvi.72.1.504-511.1998 |
0.492 |
|
| Show low-probability matches. |